Agilent Technologies Inc. (A) and MRM Proteomics Introduce First Commercial Kits for Quality Control of MRM-Based Quantitative Plasma Proteomic Workflows  
10/9/2013 9:58:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and MRM Proteomics Inc. today announced the launch of MRM Proteomics’ PeptiQuant MRM Assay Kits for quality control in quantitative plasma proteomic analyses based on multiple-reaction monitoring.

Help employers find you! Check out all the jobs and post your resume.